Millions of people take medications that will not help them. As health data proliferates, it is becoming evident that clinical trial outcomes are routinely not replicated in the real world.
The pharmaceutical industry can look elsewhere for outcomes. In services. A services-founded approach enables product and medical device companies, pharmaceutical companies, “Big Pharma” and emerging biotechs to improve clinical and economic outcomes. This approach can help companies deliver new value to customers and strengthen competitiveness.
True services-founded offerings may also command new revenue streams themselves. Realizing these gains demands rethinking services, transforming how they are designed, deployed and measured to fuel growth, profitability and trust.READ REPORT [PDF]